© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

Drug slows cognitive decline in Alzheimer’s patients, study reveals

Antibody therapy lecanemab removes clumps of protein called beta amyloid that builds up in brain

Researchers have hailed the dawn of a new era of Alzheimer’s therapies after a clinical trial confirmed that a drug slows cognitive decline in patients with early stages of the disease.

The result comes after decades of failure in the field and encouraged experts to say Alzheimer’s – which affects 30 million people worldwide – could be treatable.

Continue reading…

Related posts

UK announces extra £29m of humanitarian aid for Ethiopia

AEA3

England v Croatia: Euro 2020 – live!

AEA3

Tory quarrels determined UK’s post-Brexit future, says Barnier

AEA3

Pin It on Pinterest

Share This